CarnoSyn® Brands presents TriBsyn at the 46th ESPEN Congress for Clinical Nutrition and Substance Exchange

CARLSBAD, California, August 26, 2024 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (NAI) and CarnoSyn^® Brands were presented at the 46th ESPEN Congress for Clinical Nutrition and Substance Change from 7 to 10 September 2024 in Milan, Italy. ESPEN 2024 offers a unique platform for research, innovative research into clinical trials and substances for presentations and research and preparation with medicines, medicines, pharmacists, nutritionists, scientists and nurses to promote.

The NAI and CarnoSyn team^® Brands are listed at Stand No. 16 This is the result of the new clinical recognition of the results and the formal application of the patent, the use of a well-developed technology, the use of biofertilization and the absorption of beta-alanin and the improvement of the results of the parästhesia. work together Beta -Alanin-Dosierungen verbunden ist, wirksam zu seitigen. TriBsyn offers new opportunities, which provide a number of experiences, who are vegan and all interested in wellness. The conference steeplehmer has been loaded, the state of affairs is more than this new product innovation.

Aaron Starr, Vice Chairman of CarnoSyn^® Brands, explanation: “We are happy to discuss the results of the ESPEN Conference for Clinical Research and Material Development and the details of the clinical results for the future. It is important to be prepared and wait for the future results and Wellness, and The patented protection of Carnosin-Booster is a Wendepunkt in the category of the pharmaceutical and medical lifestyle, which “concentrates” on the vitality of the musk, the cognitive lifestyle and the anti-aging treatment.

I joined ESPEN with the team of 20. Kongress der Europäischen Gesellschaft für Geriatrie (EuGMS) from September 18 to 20 in Valencia, Spain, teilnehmen.

Find more information about TriBsyn at ESPEN Stand No. 16 or at www.tribsyn.com.

About CarnoSyn^® To notice:
CarnoSyn^® Brands that conduct clinical research, patent the pharmaceutical products, which are offered exclusively to Natural Alternatives International, Inc.: CarnoSyn^® Beta-Alanin-Pulver with softer Freisetzung, SR CarnoSyn^® Beta-Alanin Tablets with Verzögerter Freisetzung and TriBsyn Pulver. I am Jahr 2019 erhielt CarnoSyn^® Beta-Alanine follows FDA NDI status and self-best GRAS status. More information on the new Innovation, TriBsyn, can be found at www.tribsyn.com.

About NAI:
NAI, with Hauptsitz in Carlsbad, California, is a führender Formulierer, Hersteller und Vermarkter von Nahrungsergänzungsmitteln and offers an excellent strategic partnership service. NAIs offer partnerships with the opportunity to develop an innovative palette, product and service development, individual product development, geschützter inhaltsstoffe, specialized product development, product testing and processing, marketing management and implementation, packaging and packaging system design, study the Überpr üfunction and Unterstützung at international product registration. For more information about the NAI, please visit www.nai-online.com.

Contact:
Renee Michaelson
Director of Global Marketing
NAI/CarnoSyn^® To notice